JP Morgan Upgrades CME Group to Overweight, Announces $367 Price Target
JP Morgan analyst Kenneth Worthington upgrades CME Group (NASDAQ:CME) from Underweight to Overweight and announces $367 price target.
Share
Why It Matters
A big bank analyst thinks CME Group looks like a better investment now. This suggests the analyst sees good things ahead for the company.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.